[ 10] This may be the result of inadequate nutrition and/or physical exercise when relying solely on GLP-1 agonists for weight management
NAION is one of the conditions that has led people to sue the GLP-1 drugs manufacturer, Novo Nordisk
Semaglutide, originally developed for the treatment of type 2 diabetes, has gained attention for its ability to promote weight loss and possibly reduce inflammation
Significant price cut, significant volume growth On JD, Meituan, and Pinduoduo platforms, the new pre - sale prices of Tirzepatide have all dropped significantly, and they will be implemented starting from January 2026, highly consistent with the official implementation time of the national medical insurance catalog
B-vitamins: These convert food into a cellular energy source
Joanna Kopciska (Department of Applied Mathematics, Faculty of Environmental Engineering and Land Surveying, University of Agriculture in Krakow) for consultations in the field of statistical analysis of results